Magnetic Resonance (MR) Imaging With Hyperpolarized Pyruvate (HP) (13C) in Castration-Resistant Prostate Cancer

NCT02911467 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

8

Enrollment

OTHER

Sponsor class

Stopped Low Accrual

Conditions

Prostate Cancer

Interventions

DRUG: Pyruvate (13C)
DEVICE: MRI

Sponsor

Rahul Aggarwal

Collaborators

[object Object]